Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

NCT02287311 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Disease
Non-Hodgkin Lymphoma
Severe Chronic Active Epstein Barr Virus
T/NK-lymphoproliferative Disease
Nasopharyngeal Carcinoma
Smooth Muscle Tumor

Interventions

BIOLOGICAL: MABEL CTLs
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]